Pancreatic adenocarcinoma tumor grade determination using contrast-enhanced magnetic resonance imaging

Thomas C. Lauenstein, Diego R Martin, Juan M. Sarmiento, Bobby T Kalb, Roger Moreira, John Carew, Khalil Salman, Volkan Adsay

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objectives: To determine whether the degree of enhancement of pancreatic adenocarcinoma visualized on arterial phase gadolinium-enhanced magnetic resonance imaging (MRI) correlates with the histopathological tumor grade. Methods: Thirty-nine patients with pancreatic adenocarcinoma had MRI within 14 days before tumor resection. Gadolinium-chelate-enhanced (Gd) 3-dimensional gradient echo images were acquired including the arterial phase. Tumor imaging patterns on the arterial phase images were classified for low, moderate, or high degree of enhancement and compared against conventional histological grading. Results: Based on histological grading, there were 12 poorly differentiated, 2 poorly to moderately differentiated, 22 moderately differentiated, and 3 well-differentiated adenocarcinomas. There was agreement between the MRI arterial enhancement pattern and histological grading in 30 of 39 cases. The mean size of tumors grouped by enhancement pattern or grade was not significantly different between groups. Although minor discordance was found in 9 of the 39 cases, statistical analysis showed agreement between the degree of arterial enhancement on MRI and histological tumor differentiation; the Cohen's kappa value was 0.64 with a 95% confidence interval of 0.46-0.83. Conclusions: Pancreatic adenocarcinoma arterial phase enhancement correlates with the histological grade of differentiation.

Original languageEnglish (US)
Pages (from-to)71-75
Number of pages5
JournalPancreas
Volume39
Issue number1
DOIs
StatePublished - Jan 2010
Externally publishedYes

Fingerprint

Adenocarcinoma
Magnetic Resonance Imaging
Gadolinium
Neoplasms
Confidence Intervals

Keywords

  • Enhancement
  • MRI
  • Noninvasive evaluation
  • Pancreatic adenocarcinoma
  • Tumor histology

ASJC Scopus subject areas

  • Hepatology
  • Internal Medicine
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Pancreatic adenocarcinoma tumor grade determination using contrast-enhanced magnetic resonance imaging. / Lauenstein, Thomas C.; Martin, Diego R; Sarmiento, Juan M.; Kalb, Bobby T; Moreira, Roger; Carew, John; Salman, Khalil; Adsay, Volkan.

In: Pancreas, Vol. 39, No. 1, 01.2010, p. 71-75.

Research output: Contribution to journalArticle

Lauenstein, Thomas C. ; Martin, Diego R ; Sarmiento, Juan M. ; Kalb, Bobby T ; Moreira, Roger ; Carew, John ; Salman, Khalil ; Adsay, Volkan. / Pancreatic adenocarcinoma tumor grade determination using contrast-enhanced magnetic resonance imaging. In: Pancreas. 2010 ; Vol. 39, No. 1. pp. 71-75.
@article{c1c6914b1bc143fdaa9769af22743589,
title = "Pancreatic adenocarcinoma tumor grade determination using contrast-enhanced magnetic resonance imaging",
abstract = "Objectives: To determine whether the degree of enhancement of pancreatic adenocarcinoma visualized on arterial phase gadolinium-enhanced magnetic resonance imaging (MRI) correlates with the histopathological tumor grade. Methods: Thirty-nine patients with pancreatic adenocarcinoma had MRI within 14 days before tumor resection. Gadolinium-chelate-enhanced (Gd) 3-dimensional gradient echo images were acquired including the arterial phase. Tumor imaging patterns on the arterial phase images were classified for low, moderate, or high degree of enhancement and compared against conventional histological grading. Results: Based on histological grading, there were 12 poorly differentiated, 2 poorly to moderately differentiated, 22 moderately differentiated, and 3 well-differentiated adenocarcinomas. There was agreement between the MRI arterial enhancement pattern and histological grading in 30 of 39 cases. The mean size of tumors grouped by enhancement pattern or grade was not significantly different between groups. Although minor discordance was found in 9 of the 39 cases, statistical analysis showed agreement between the degree of arterial enhancement on MRI and histological tumor differentiation; the Cohen's kappa value was 0.64 with a 95{\%} confidence interval of 0.46-0.83. Conclusions: Pancreatic adenocarcinoma arterial phase enhancement correlates with the histological grade of differentiation.",
keywords = "Enhancement, MRI, Noninvasive evaluation, Pancreatic adenocarcinoma, Tumor histology",
author = "Lauenstein, {Thomas C.} and Martin, {Diego R} and Sarmiento, {Juan M.} and Kalb, {Bobby T} and Roger Moreira and John Carew and Khalil Salman and Volkan Adsay",
year = "2010",
month = "1",
doi = "10.1097/MPA.0b013e3181b9ed55",
language = "English (US)",
volume = "39",
pages = "71--75",
journal = "Pancreas",
issn = "0885-3177",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Pancreatic adenocarcinoma tumor grade determination using contrast-enhanced magnetic resonance imaging

AU - Lauenstein, Thomas C.

AU - Martin, Diego R

AU - Sarmiento, Juan M.

AU - Kalb, Bobby T

AU - Moreira, Roger

AU - Carew, John

AU - Salman, Khalil

AU - Adsay, Volkan

PY - 2010/1

Y1 - 2010/1

N2 - Objectives: To determine whether the degree of enhancement of pancreatic adenocarcinoma visualized on arterial phase gadolinium-enhanced magnetic resonance imaging (MRI) correlates with the histopathological tumor grade. Methods: Thirty-nine patients with pancreatic adenocarcinoma had MRI within 14 days before tumor resection. Gadolinium-chelate-enhanced (Gd) 3-dimensional gradient echo images were acquired including the arterial phase. Tumor imaging patterns on the arterial phase images were classified for low, moderate, or high degree of enhancement and compared against conventional histological grading. Results: Based on histological grading, there were 12 poorly differentiated, 2 poorly to moderately differentiated, 22 moderately differentiated, and 3 well-differentiated adenocarcinomas. There was agreement between the MRI arterial enhancement pattern and histological grading in 30 of 39 cases. The mean size of tumors grouped by enhancement pattern or grade was not significantly different between groups. Although minor discordance was found in 9 of the 39 cases, statistical analysis showed agreement between the degree of arterial enhancement on MRI and histological tumor differentiation; the Cohen's kappa value was 0.64 with a 95% confidence interval of 0.46-0.83. Conclusions: Pancreatic adenocarcinoma arterial phase enhancement correlates with the histological grade of differentiation.

AB - Objectives: To determine whether the degree of enhancement of pancreatic adenocarcinoma visualized on arterial phase gadolinium-enhanced magnetic resonance imaging (MRI) correlates with the histopathological tumor grade. Methods: Thirty-nine patients with pancreatic adenocarcinoma had MRI within 14 days before tumor resection. Gadolinium-chelate-enhanced (Gd) 3-dimensional gradient echo images were acquired including the arterial phase. Tumor imaging patterns on the arterial phase images were classified for low, moderate, or high degree of enhancement and compared against conventional histological grading. Results: Based on histological grading, there were 12 poorly differentiated, 2 poorly to moderately differentiated, 22 moderately differentiated, and 3 well-differentiated adenocarcinomas. There was agreement between the MRI arterial enhancement pattern and histological grading in 30 of 39 cases. The mean size of tumors grouped by enhancement pattern or grade was not significantly different between groups. Although minor discordance was found in 9 of the 39 cases, statistical analysis showed agreement between the degree of arterial enhancement on MRI and histological tumor differentiation; the Cohen's kappa value was 0.64 with a 95% confidence interval of 0.46-0.83. Conclusions: Pancreatic adenocarcinoma arterial phase enhancement correlates with the histological grade of differentiation.

KW - Enhancement

KW - MRI

KW - Noninvasive evaluation

KW - Pancreatic adenocarcinoma

KW - Tumor histology

UR - http://www.scopus.com/inward/record.url?scp=74049151899&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74049151899&partnerID=8YFLogxK

U2 - 10.1097/MPA.0b013e3181b9ed55

DO - 10.1097/MPA.0b013e3181b9ed55

M3 - Article

C2 - 19745775

AN - SCOPUS:74049151899

VL - 39

SP - 71

EP - 75

JO - Pancreas

JF - Pancreas

SN - 0885-3177

IS - 1

ER -